logo
  

Accenture, Toshiba To Provide Consulting Services To Support Green Transformation Across Enterprise

Accenture (ACN) said it has collaborated with Toshiba to provide consulting services to support green transformation efforts of the companies' clients. The collaboration will target industries with high greenhouse gas emissions and other organizations with urgent needs to improve energy efficiency.

Accenture noted that it will leverage its experience developing circular-economy business models and implementing sustainable supply chain processes, such as green procurement, as well as using cloud and other technology solutions from its partner ecosystem.

Toshiba brings with it a robust stable of existing carbon-neutrality technologies and services to the collaboration, including renewable energy systems, digital energy management systems, renewable energy-derived hydrogen solutions, and carbon dioxide capture and recovery facilities.

Toshiba aims to achieve carbon neutrality throughout its entire value chain by fiscal 2050. It has set a preliminary goal for fiscal 2030 of cutting greenhouse gas emissions by 70% from fiscal 2019 levels.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Health insurer Humana Inc. reported Wednesday a net loss for the fourth quarter that slightly widened from last year, hurt primarily by charges associated with productivity initiatives, despite 6.6 percent revenue growth. Adjusted earnings for the quarter topped analysts' expectations, while quarterly revenues missed it by a whisker. South Plainfield, New Jersey-based Two Rivers Coffee is recalling its peanut butter single serve hot chocolate pods citing an undeclared peanut allergen, the U.S. Food Drug Administration said. The recall involves peanut butter single serve hot chocolate pods distributed as "Brooklyn Bean Peanut Butter Cup Hot Cocoa", "Pingo Peanut Butter Cookie Hot Chocolate" and ... Shares of Novartis AG were losing around 2 percent in the early morning trading in Switzerland after the drug major reported Wednesday sharply lower profit in its fourth quarter with weak sales as well as the absence of prior year's hefty Roche income. Adjusted earnings, however, topped market estimates, while top line missed their view. Further, the company announced higher dividend...
Follow RTT